Developmental disabilities after in utero exposure to topiramate News item 01 April 2023 Pages: 2 - 2
GLP-1 receptor agonists and tirzepatide gall bladder-related AEs News item 01 April 2023 Pages: 4 - 4
Measures for reducing risks of respiratory failure and sepsis with terlipressin News item 01 April 2023 Pages: 6 - 6
Piperacillin/tazobactam-related haemophagocytic lymphohistiocytosis News item 01 April 2023 Pages: 7 - 7
Baseline factors associated with pemetrexed-related acute toxicity Clinical study 01 April 2023 Pages: 8 - 8
Emicizumab: positive AE signals for arthralgia and injection-site pain, but also for some serious AEs Clinical study 01 April 2023 Pages: 9 - 9
Subgroups at high and low risk of tofacitinib-related cancer and MACE Clinical study 01 April 2023 Pages: 11 - 11
Talimogene laherparepvec increases risk of skin disorders in patients receiving ICIs Clinical study 01 April 2023 Pages: 12 - 12